Biomarkers for Early Diagnosis of AKI: Could It Backfire?

Simple item page
dc.contributor.authorClaure-Del Granado, Rolando
dc.contributor.authorMacedo, Etienne
dc.contributor.authorChávez-Íñiguez, Jonathan S
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-24T15:03:27Z
dc.date.available2026-03-24T15:03:27Z
dc.date.issued2022
dc.descriptionVol. 3, No. 10, pp. 1780-1784
dc.description.sponsorshipDivision of Nephrology Hospital Obrero No. 2-CNS, Cochabamba, Bolivia. | IIBISMED, Universidad Mayor de San Simon, School of Medicine, Cochabamba, Bolivia. | Division of Nephrology-Hypertension University of California, San Diego, San Diego, California.
dc.identifier.doi10.34067/KID.0001012022
dc.identifier.issn2641-7650
dc.identifier.otherPMID:36514722
dc.identifier.urihttps://doi.org/10.34067/KID.0001012022
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/100949
dc.language.isoeng
dc.relation.ispartofKidney360
dc.sourcePubMed
dc.subjectacute kidney injury
dc.subjectacute kidney injury and ICU nephrology
dc.subjectbiomarkers
dc.subjectcreatinine
dc.titleBiomarkers for Early Diagnosis of AKI: Could It Backfire?
dc.typeArtículo Científico Publicado

Files

Collections

Artículo Científico Publicado